The paper by the ICT Patras team CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE was accepted to the EHA Hybrid Congress 2023 and was awarded a travel grant.
This website uses cookies to improve your web experience.